Page last updated: 2024-08-24

fluorodeoxyglucose f18 and osimertinib

fluorodeoxyglucose f18 has been researched along with osimertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kawaguchi, T; Ota, M; Taniguchi, S; Tojo, T; Yasukawa, M	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and osimertinib

Article	Year
[Effectiveness of Osimertinib for Postoperative Recurrence of Lung Cancer with L861Q Activating EGFR Mutation:Report of a Case]. Kyobu geka. The Japanese journal of thoracic surgery, 2021, Volume: 74, Issue:2 Topics: Acrylamides; Aged; Aniline Compounds; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography	2021

Article

Year

[Effectiveness of Osimertinib for Postoperative Recurrence of Lung Cancer with L861Q Activating EGFR Mutation:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery, 2021, Volume: 74, Issue:2

Topics: Acrylamides; Aged; Aniline Compounds; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography

2021